Manufacturing Process (GMP)

Caprine serum is sourced from Australasia in view of that region's favourable Transmissible Spongioform Encephalopathy (TSE) profile.

Manufacturing takes place in the United Kingdom and Australia at cGMP. AIMSPRO is listed on the Export Only section of the Australian Therapeutic Goods Register and appropriate Certificates of Pharmaceutical product have been issued, including for North America and Europe.

Back to AIMSPRO

    5th Nov 2009
AIMSPRO receives US orphan-drug designation for ALS
    29th Sep 2009
Ceremben Permit Approved
    22nd Jul 2009
Patent granted by the OAPI
Design by